Clovis Oncology, Inc.

VANGUARD GROUP INC

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

10,206,509

Value ($000)

12,146

Weight

0.0%

2013 Q4 - 2022 Q3 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	12,146	0.0%	10,206,509	9/30/2022
2022 Q2	8/12/2022	20,202	0.0%	11,223,237	6/30/2022
2022 Q1	5/13/2022	24,945	0.0%	12,348,898	3/31/2022
2021 Q4	2/14/2022	27,412	0.0%	10,115,101	12/31/2021
2021 Q3	11/12/2021	54,835	0.0%	12,294,891	9/30/2021
2021 Q2	8/13/2021	57,502	0.0%	9,914,068	6/30/2021
2021 Q1	5/14/2021	53,516	0.0%	7,623,193	3/31/2021
2020 Q4	2/12/2021	30,661	0.0%	6,387,554	12/31/2020
2020 Q3	11/16/2020	36,044	0.0%	6,182,479	9/30/2020
2020 Q2	8/14/2020	42,153	0.0%	6,244,924	6/30/2020
2020 Q1	5/15/2020	28,348	0.0%	4,457,259	3/31/2020
2019 Q4	2/14/2020	43,976	0.0%	4,218,344	12/31/2019
2014 Q2	8/11/2014	55,620	0.0%	1,343,141	6/30/2014
2014 Q1	5/13/2014	90,749	0.0%	1,310,076	3/31/2014
2013 Q4	2/12/2014	75,714	0.0%	1,256,258	12/31/2013